Schedule 13G ownership disclosure
Neumora Therapeutics Inc
COMMON STOCK · CUSIP: 640979100
Event date: 2024-06-28
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 8,622,468.00 · Class: 5.4%
- Abigail P. Johnson
Shares: 8,622,468.00 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-24-001795
- Form type
- SCHEDULE 13G
- Filer
- FMR LLC
- CIK
- CIK 315066
- Filed
- Jul 08, 2024
- Reporting period
- Jun 28, 2024
- Description
- Schedule 13G beneficial ownership